Eurofins Scientific SE (ERFSF)
USD 49.72
(0.0%)
USD 49.72
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 620.4 Million EUR | -86.17% |
| 2022 | 4.48 Billion EUR | -1.81% |
| 2021 | 4.56 Billion EUR | 23.77% |
| 2020 | 3.69 Billion EUR | 20.63% |
| 2019 | 3.05 Billion EUR | 25.79% |
| 2018 | 2.43 Billion EUR | 27.54% |
| 2017 | 1.9 Billion EUR | 16.35% |
| 2016 | 1.63 Billion EUR | 29.58% |
| 2015 | 1.26 Billion EUR | 37.97% |
| 2014 | 916.8 Million EUR | 16.34% |
| 2013 | 788.04 Million EUR | 17.32% |
| 2012 | 671.7 Million EUR | 25.63% |
| 2011 | 534.69 Million EUR | 25.29% |
| 2010 | 426.75 Million EUR | 9.61% |
| 2009 | 389.32 Million EUR | 2.14% |
| 2008 | 381.15 Million EUR | 31.69% |
| 2007 | 289.42 Million EUR | 31.51% |
| 2006 | 220.08 Million EUR | 47.05% |
| 2005 | 149.66 Million EUR | 31.58% |
| 2004 | 113.74 Million EUR | 9.56% |
| 2003 | 103.81 Million EUR | 9.29% |
| 2002 | 94.99 Million EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 756.6 Million EUR | 0.0% |
| 2023 Q2 | 266.9 Million EUR | 0.0% |
| 2023 FY | 620.4 Million EUR | -86.17% |
| 2023 Q4 | 279.9 Million EUR | 0.0% |
| 2022 Q4 | 290.4 Million EUR | 0.0% |
| 2022 FY | 4.48 Billion EUR | -1.81% |
| 2022 Q2 | 492.8 Million EUR | 0.0% |
| 2021 FY | 4.56 Billion EUR | 23.77% |
| 2021 Q2 | 729.8 Million EUR | 0.0% |
| 2021 Q4 | 539.8 Million EUR | 0.0% |
| 2020 Q4 | 602.3 Million EUR | 0.0% |
| 2020 FY | 3.69 Billion EUR | 20.63% |
| 2020 Q2 | 203.2 Million EUR | 0.0% |
| 2019 Q2 | 132.15 Million EUR | 0.0% |
| 2019 FY | 3.05 Billion EUR | 25.79% |
| 2019 Q4 | 234.44 Million EUR | 0.0% |
| 2018 Q2 | 320.35 Million EUR | 0.0% |
| 2018 FY | 2.43 Billion EUR | 27.54% |
| 2018 Q4 | 399.34 Million EUR | 0.0% |
| 2017 Q2 | 250.09 Million EUR | 0.0% |
| 2017 Q4 | 306.62 Million EUR | 0.0% |
| 2017 FY | 1.9 Billion EUR | 16.35% |
| 2016 Q2 | 216.58 Million EUR | 0.0% |
| 2016 Q4 | 263.03 Million EUR | 0.0% |
| 2016 FY | 1.63 Billion EUR | 29.58% |
| 2015 FY | 1.26 Billion EUR | 37.97% |
| 2015 Q2 | 142.21 Million EUR | 0.0% |
| 2015 Q4 | 218.58 Million EUR | 0.0% |
| 2014 FY | 916.8 Million EUR | 16.34% |
| 2014 Q4 | 151.43 Million EUR | 0.0% |
| 2014 Q2 | 108.99 Million EUR | 0.0% |
| 2013 Q4 | 111.66 Million EUR | 0.0% |
| 2013 Q2 | 93.08 Million EUR | 0.0% |
| 2013 FY | 788.04 Million EUR | 17.32% |
| 2012 Q2 | - EUR | 0.0% |
| 2012 Q4 | - EUR | 0.0% |
| 2012 FY | 671.7 Million EUR | 25.63% |
| 2011 Q1 | 102.13 Million EUR | -79.77% |
| 2011 Q4 | 157.44 Million EUR | 12.3% |
| 2011 Q2 | 134.91 Million EUR | 32.1% |
| 2011 Q3 | 140.19 Million EUR | 3.91% |
| 2011 FY | 534.69 Million EUR | 25.29% |
| 2010 Q1 | 90.13 Million EUR | -68.68% |
| 2010 Q2 | 106.71 Million EUR | 18.39% |
| 2010 Q3 | 308.75 Million EUR | 189.33% |
| 2010 Q4 | 504.91 Million EUR | 63.53% |
| 2010 FY | 426.75 Million EUR | 9.61% |
| 2009 FY | 389.32 Million EUR | 2.14% |
| 2009 Q4 | 287.81 Million EUR | 1.01% |
| 2009 Q3 | 284.93 Million EUR | 201.11% |
| 2009 Q1 | 88.79 Million EUR | 0.0% |
| 2009 Q2 | 94.63 Million EUR | 6.57% |
| 2008 FY | 381.15 Million EUR | 31.69% |
| 2007 FY | 289.42 Million EUR | 31.51% |
| 2006 FY | 220.08 Million EUR | 47.05% |
| 2005 FY | 149.66 Million EUR | 31.58% |
| 2004 FY | 113.74 Million EUR | 9.56% |
| 2003 FY | 103.81 Million EUR | 9.29% |
| 2002 FY | 94.99 Million EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Bio Medica Corporation | -193 Thousand USD | 321550.777% |
| Arrayit Corporation | 2.57 Million USD | -23992.661% |
| Atlantic International Corp. | -154.23 Thousand USD | 402345.938% |
| Biocept, Inc. | -2.58 Million USD | 24127.885% |
| Bioqual, Inc. | 7.42 Million USD | -8250.907% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 276 Thousand USD | -224682.609% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 6.73 Billion USD | 90.795% |
| HTG Molecular Diagnostics, Inc. | 1.79 Million USD | -34480.282% |
| iMD Companies, Inc. | -23.63 Thousand USD | 2624798.566% |
| IDenta Corp. | 662.97 Thousand USD | -93478.189% |
| Interpace Biosciences, Inc. | 23.04 Million USD | -2592.358% |
| Integrative Health Technologies, Inc. | 77.57 Thousand USD | -799683.424% |
| InVitro International | 635.98 Thousand USD | -97449.471% |
| Lumos Diagnostics Holdings Limited | 6.56 Million USD | -9352.994% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 1.09 Million USD | -56677.623% |
| NovelStem International Corp. | 12 Thousand USD | -5169900.0% |
| Optigenex Inc. | -102.96 Thousand USD | 602628.99% |
| PharmChem, Inc. | 3.9 Million USD | -15789.863% |
| Proteome Sciences plc | 2.09 Million USD | -29490.328% |
| Response Genetics, Inc | 3.94 Million USD | -15638.204% |
| Rennova Health, Inc. | 6.26 Million USD | -9797.498% |
| RushNet, Inc. | 1.1 Million USD | -56064.365% |
| ScreenPro Security Inc. | 856.57 Thousand USD | -72328.068% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | -403.74 Thousand USD | 153760.584% |
| Todos Medical Ltd. | 4.31 Million USD | -14294.432% |